Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
4 clinical trials · Condition
◉ Watch Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) (NCT02973997) | Academic and Community Cancer Research United | 2018-02-07 |
| Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer (NCT02393690) | Academic and Community Cancer Research United | 2015-05-04 |
| Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer (NCT02152995) | National Cancer Institute (NCI) | 2014-08-14 |
| Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery (NCT00381641) | National Cancer Institute (NCI) | 2006-08-29 |
Track Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.